Mitsubishi UFJ Asset Management
MDCO

Mitsubishi UFJ Asset Management’s Medicines Co MDCO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,024
Closed -$172K – 1027
2019
Q4 		$172K Sell
2,024
-2,312
-53% -$154K ﹤0.01% 897
2019
Q3 		$217K Buy
4,336
+755
+21% +$30.1K ﹤0.01% 825
2019
Q2 		$131K Sell
3,581
-4,186
-54% -$137K ﹤0.01% 888
2019
Q1 		$217K Buy
7,767
+777
+11% +$18.3K ﹤0.01% 785
2018
Q4 		$125K Buy
6,990
+2,651
+61% +$61.7K ﹤0.01% 815
2018
Q3 		$130K Buy
+4,339
New +$163K ﹤0.01% 821

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Mitsubishi UFJ Asset Management's MDCO Position: Q1 2020 in Review

Mitsubishi UFJ Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,024 shares — an estimated $172K sold.

Mitsubishi UFJ Asset Management first reported a position in MDCO in Q3 2018 and held it in 6 quarters. The position peaked at $217K in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Mitsubishi UFJ Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 2,024 Medicines Co shares in Q1 2020, an estimated $172K.
  • Mitsubishi UFJ Asset Management first reported a position in Medicines Co in Q3 2018 and held it in 6 quarters.
  • Mitsubishi UFJ Asset Management's Medicines Co position peaked at $217K in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2020, filed 11 May 2020.